Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Institute of Allergy and Infectious Diseases (NIAID) |
---|---|
Information provided by: | National Institutes of Health Clinical Center (CC) |
ClinicalTrials.gov Identifier: | NCT00395278 |
Dr. Burbelo and colleagues have developed a technique for rapidly and quantitatively detecting antibody responses in sera to a variety of pathogens using recombinant proteins. We would like to apply this technique to develop an assay for detecting antibodies to HHV-8 (KSHV, the etiologic agents of Kaposi's sarcoma, an AIDS-defining condition). We initially plan to examine samples from patients with Kaposi's sarcoma, since all those patients are almost certainly infected with HHV-8. We are thus using samples from patients with previously diagnosed Kaposi's sarcoma. The samples in question are stored at the NCI FCRF repository operated by SAIC Frederick or in Rockville, MD.
Condition |
---|
Human Herpes Virus-8 |
Study Type: | Observational |
Study Design: | Natural History |
Official Title: | Development of Serologic Assays for Human Herpes Virus-8 |
Estimated Enrollment: | 100 |
Study Start Date: | October 2006 |
Estimated Study Completion Date: | September 2006 |
Dr. Burbelo and colleagues have developed a technique for rapidly and quantitatively detecting antibody responses in sera to a variety of pathogens using recombinant proteins. We would like to apply this technique to develop an assay for detecting antibodies to HHV-8 (KSHV, the etiologic agents of Kaposi's sarcoma, an AIDS-defining condition). We initially plan to examine samples from patients with Kaposi's sarcoma, since all those patients are almost certainly infected with HHV-8. We are thus using samples from patients with previously diagnosed Kaposi's sarcoma. The samples in question are stored at the NCI FCRF repository operated by SAIC Frederick or in Rockville, MD.
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
-Data analysis only.
Contact: Patient Recruitment and Public Liaison Office | (800) 411-1222 | prpl@mail.cc.nih.gov |
Contact: TTY | 1-866-411-1010 |
United States, Maryland | |
National Institute of Allergy and Infectious Diseases (NIAID) | Recruiting |
Bethesda, Maryland, United States, 20892 |
Study ID Numbers: | 999907018, 07-CC-N018 |
Study First Received: | October 31, 2006 |
Last Updated: | November 2, 2006 |
ClinicalTrials.gov Identifier: | NCT00395278 History of Changes |
Health Authority: | United States: Federal Government |
KSHV Kaposi's Sarcoma HIV |
Virus Diseases Soft Tissue Sarcomas Malignant Mesenchymal Tumor HIV Infections |
Sarcoma, Kaposi Acquired Immunodeficiency Syndrome Sarcoma Kaposi Sarcoma |